Helius Launches $500M Solana Treasury; Shares Jump 140%
Nasdaq-listed Helius Medical Technologies completed an oversubscribed $500 million PIPE offering. The deal was led by Pantera Capital and Summer Capital. Investors bought common stock at $6.88 and stapled warrants at $10.13, exercisable over three years. Up to $750 million in additional warrants could raise total capital to $1.25 billion. Helius will build a long-term Solana treasury, scaling its SOL holdings over 12–24 months. Solana’s native staking yield is about 7%. Helius aims to boost shareholder value through staking and lending programs. Its stock jumped 140% intraday after the announcement. The Solana treasury strategy aligns Helius’s balance sheet with the Solana ecosystem. This PIPE offering signals institutional confidence and growing adoption of SOL. Traders should monitor SOL price trends and Helius filings for trading opportunities.
Bullish
Helius’s $500 million Solana treasury PIPE offering and stock surge indicate strong institutional demand for SOL. By allocating corporate reserves to SOL and earning ~7% staking yield, Helius underscores Solana’s growing role as a yield-bearing asset. In the short term, increased corporate buying pressure could drive SOL prices higher. Over the long term, other public firms following suit may support sustained demand and reduced market volatility. Traders can expect a bullish outlook for SOL as more companies adopt Solana treasury strategies.